MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Spinocerebellar ataxia"

  • 2025 International Congress

    Brainstem Subsegmentation in Spinocerebellar Ataxia Type 3 (SCA3)

    K. Teichmann (Bonn, Germany)

    Objective: The aim of our work is to create a novel protocol for manual subsegmentation of the human brainstem for creating accurate brainstem labels for…
  • 2025 International Congress

    Genetic Profile of Cerebellar Ataxias in Patients from a Reference Center in Brazil

    S. Baran, N. Dos Santos, G. de Vasconcelos, J. Costa, R. Kauark, F. Brito (Salvador, Brazil)

    Objective: To describe the genetic profile of patients with cerebellar ataxias followed in a neurogenetics reference center in Brazil Background: Cerebellar ataxias comprise a heterogeneous…
  • 2025 International Congress

    A case of ataxia and muscle stiffness in EEF2 gene mutation with associated anti-GAD antibodies

    H. Arrowood, J. Tamai (Poughkeepsie, USA)

    Objective: Here we present a case of ataxia and muscle stiffness in a person with variant EEF2 gene mutation with associated anti-GAD antibodies along with…
  • 2025 International Congress

    Assessment of mitochondrial DNA copy number and common deletion (del4977) as candidate peripheral biomarkers for Spinocerebellar ataxia type 2

    LE. Almaguer Mederos, D. Cuello Almarales, R. Aguilera Rodríguez, D. Almaguer Gotay, DO. Palenzuela Gardon, H. Camacho Rodríguez, A. Estupiñán Rodríguez, N. Canales Ochoa, S. Gispert, G. Auburger (Frankfurt am Main, Germany)

    Objective: Assessing the relevance of mtDNA copy number (mtDNAcn) and its common deletion (del4977) as candidate peripheral biomarkers for Spinocerebellar ataxia type 2 (SCA2). Background:…
  • 2025 International Congress

    From Explainable AI to Biomarkers: Identifying Disease-Related Brain Regions in Spinocerebellar Ataxia Type 3

    P. Wegner, M. Ferreira, J. Theisen, T. Klockgether, J. Faber (Bonn, Germany)

    Objective: This study aims to classify healthy control (HC) participants, pre-symptomatic Spinocerebellar Ataxia Type 3 (SCA3) patients (preSCA3), and symptomatic SCA3 patients (SCA3) by processing…
  • 2025 International Congress

    Spinocerebellar Ataxia Recessive Type 7 (SCAR7) in a Consanguineous Family: A Case Report

    T. Ozum, O. Akcin, C. Durmaz, G. Yalcin Cakmakli, B. Elibol (Ankara, Turkey)

    Objective: Spinocerebellar ataxia autosomal recessive type 7 (SCAR7) is a rare disorder caused by biallelic pathogenic variants in TPP1. It usually manifests in childhood or…
  • 2025 International Congress

    A Case Report of Two Affected Siblings with Spinocerebellar Ataxia Type 1

    S. Fu, U. Agarwal, I. Goldszer (Detroit, USA)

    Objective: To present a case of two affected siblings with Spinocerebellar ataxia type 1 Background: Spinocerebellar ataxia type 1 (SCA1) is an autosomal dominant neurodegenerative…
  • 2025 International Congress

    Turning Points in Disease Progression: Detecting MRI Biomarker Transitions in SCA3 Using Longitudinal Data

    M. Ferreira, P. Wegner, T. Klockgether, J. Faber (Bonn, Germany)

    Objective: This study aims to identify data-driven turning points in MRI biomarkers of SCA3 to characterize region-specific disease transitions and inform early intervention strategies. Background: SCA3…
  • 2025 International Congress

    Brain Structural Impairment in Spinocerebellar Ataxia Type 6: Not Restricted to the Cerebellum

    B. Massuyama, T. Rezende, M. Junior, O. Barsottini, J. Pedroso (Campinas, Brazil)

    Objective: To characterize the structural brain signature in SCA6 patients. Background: Spinocerebellar ataxias (SCA) refer to a group of autosomal dominant ataxic disorders that result…
  • 2025 International Congress

    Progressive Ataxia in a Young Patient: Atypical Presentation of a Probable Creutzfeldt-Jakob Disease Variant VV1

    F. R. Rodrigues, D. S. Rocha, D. M. Natividade, J. D. Péres, D. Di Luca, L. B. Magalhães (Vicosa, Brazil)

    Objective: To report an unusual presentation of probable Creutzfeldt-Jakob disease (CJD) subtype VV1 in a 27-year-old man. Background: CJD is a rare prion neurodegenerative disorder…
  • 1
  • 2
  • 3
  • …
  • 9
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley